Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samson W Fine

Showing results (121-130 of 175) with videos related to

Pageof 18
Sort By:
The American Journal of Surgical Pathology|May 21, 2019
In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical RecurrenceYujiro Ito, Emily A Vertosick, Daniel D Sjoberg, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]Johannes Giedl, Peter J Wild, Robert Stoehr, et al.
The Journal of Urology|January 9, 2018
Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?Daniel P Nguyen, Emily A Vertosick, Vidit Sharma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2021
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcomePaari Murugan, Liwei Jia, Renzo G Dinatale, et al.
The American Journal of Surgical Pathology|January 21, 2014
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistryYing-Bei Chen, A Rose Brannon, Antoun Toubaji, et al.
BJU International|June 23, 2021
Clinical utility of subclassifying positive surgical margins at radical prostatectomyShawn Dason, Emily A Vertosick, Kazuma Udo, et al.
The Journal of Urology|October 10, 2018
Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate CancerYujiro Ito, Kazuma Udo, Emily A Vertosick, et al.
The Journal of Urology|August 5, 2018
Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerLucas W Dean, Melissa Assel, Daniel D Sjoberg, et al.
Archives of Pathology & Laboratory Medicine|October 9, 2018
Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate CancerLiana B Guedes, Carlos L Morais, Helen Fedor, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
Pageof 18

Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
The American Journal of Surgical Pathology|May 21, 2019
In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical RecurrenceYujiro Ito, Emily A Vertosick, Daniel D Sjoberg, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]Johannes Giedl, Peter J Wild, Robert Stoehr, et al.
The Journal of Urology|January 9, 2018
Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?Daniel P Nguyen, Emily A Vertosick, Vidit Sharma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2021
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcomePaari Murugan, Liwei Jia, Renzo G Dinatale, et al.
The American Journal of Surgical Pathology|January 21, 2014
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistryYing-Bei Chen, A Rose Brannon, Antoun Toubaji, et al.
BJU International|June 23, 2021
Clinical utility of subclassifying positive surgical margins at radical prostatectomyShawn Dason, Emily A Vertosick, Kazuma Udo, et al.
The Journal of Urology|October 10, 2018
Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate CancerYujiro Ito, Kazuma Udo, Emily A Vertosick, et al.
The Journal of Urology|August 5, 2018
Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerLucas W Dean, Melissa Assel, Daniel D Sjoberg, et al.
Archives of Pathology & Laboratory Medicine|October 9, 2018
Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate CancerLiana B Guedes, Carlos L Morais, Helen Fedor, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
Pageof 18